USP Biologics Reference Standards

Biologics are complex molecules sourced from living organisms or their components, such as proteins, peptides, antibodies, nucleic acids or cells. Categories of therapeutic biologics include vaccines, gene therapies, and recombinant proteins. Biologics are generally large molecules, and their inherent variability poses unique challenges in their standardization and quality control, requiring robust tools to ensure product safety, purity, and potency.
The United States Pharmacopeia (USP) plays a central role in supporting biologics development by setting rigorous public standards: documentary standards containing validated methods and reference standards which are highly characterized materials demonstrated to have the appropriate qualities to support their intended use. USP Biologics Reference Standards are used globally to support the development, testing, and manufacturing of biologic medicines, helping mitigate variability and ensure batch-to-batch consistency. Developed through scientific expertise and a collaborative process between USP and expert committees comprising of volunteers from industry, health care practitioners, academia and regulatory bodies, these standards are critical for supporting regulatory compliance and maintaining confidence across the biologics lifecycle.
As biologics continue to evolve, USP Biologics Reference Standards remain essential to help in enabling consistent product quality, facilitating regulatory approvals, and advancing the safe and effective use of biologic therapies worldwide.
Products
Types of Biologics
The biologics landscape spans a wide range of modalities, each presenting distinct structural complexities and analytical challenges. USP Biologics Reference Standards are used to test for identity, purity and potency, and to ensure quality of the product throughout the product lifecycle.
Monoclonal antibodies
Monoclonal antibodies are engineered proteins that specifically target antigens. They play an important role in the treatment of cancer and autoimmune illnesses. Their specificity enables them to bind to disease-causing cells, designating them for elimination by the immune system. These antibodies are designed to interfere with certain biological processes, making them effective instruments in customized treatment.
Vaccines
Immunization using vaccines is crucial for preventing the spread of infectious diseases. They work by making the body's immune system react to a harmless version of a virus. This preparation helps the immune system find and fight real infections more effectively. Vaccines are one of the best ways to protect public health because they stop diseases like measles, the flu, and COVID-19 from spreading.
Cell and Gene Therapies
Cell and gene treatments represent cutting-edge advances in the treatment of genetic diseases and malignancies. These therapies employ genetic modification to cure diseases at their source. Gene therapy can repair damaged genes, whereas cell therapy may include the transplantation of modified cells. They carry promise for previously thought-to-be incurable illnesses, creating the possibility of revolutionary treatments.
Proteins and Peptides
Proteins and peptides are essential for cellular activities and biological processes. Therapeutically, they are used to replace or complement natural proteins that patients lack or are malfunctioning. Diabetes is treated with insulin, whereas growth hormones treat growth deficits. Their selectivity and targeted activities make them valuable therapeutic agents.
Oligonucleotides
Oligonucleotides are short RNA or DNA sequences used to modulate gene expression. They are employed in treatments for hereditary illnesses that either turn off or turn on certain genes. They can control gene function by attaching to specific genetic material. This makes them useful for treating disorders, including muscular dystrophy and some malignancies.
Heparins
Heparins are anticoagulant biologics that prevent blood clots. They have a critical role in the treatment of cardiovascular and thrombotic diseases. Heparins assist maintaining normal blood flow by suppressing clotting factors, which lowers the risk of stroke and other clot-related problems. Their therapeutic value is crucial in surgical and critical care situations.
Carbohydrates
Carbohydrates in biologics frequently function as structural components or influence biological activity. They play vital roles in cell recognition and signaling. Glycoproteins, which contain carbohydrate groups, play critical roles in immune processes. These biologic molecules are critical in vaccination efficacy, as carbohydrate structures on antigens can elicit immune responses.
Antibiotics
Antibiotics are crucial biologic drugs that combat bacterial infections by targeting microorganisms' vital functions. Their consistent quality and effectiveness are critical for combating infectious illnesses and reducing the spread of antimicrobial resistance. Antibiotics, whether natural or semi-synthetic, serve an important role in world healthcare by treating potentially fatal illnesses such as pneumonia and meningitis.
Related Resources
- Flyer: Make Quality Your Upmost Priority
Explore our range of primary reference standards for Pharma QC applications, featuring Pharmacopeia and NMI Reference Standards.
- Article: How to Choose the Correct Reference Material Quality Grade
Choose ideal reference materials for analytical testing needs, whether for calibration or quantitative analysis, ensuring accuracy and reliability.
To continue reading please sign in or create an account.
Don't Have An Account?